Last reviewed · How we verify

NCT04978467

SPiRE Maestro Hand Exoskeleton for Rehabilitation Post Stroke

Withdrawn NA Last updated 5 November 2024
What this trial tests

NA trial testing Exoskeleton in Stroke. Withdrawn.

Timeline
3 September 2024
Primary endpoint
30 September 2024
30 September 2024

Quick facts

Lead sponsorVA Office of Research and Development
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date3 September 2024
Primary completion30 September 2024
Estimated completion30 September 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The research team will develop a novel training tool to improve finger joint coordination, to address the unmet need in the current rehabilitation, thereby enhancing hand function and contributing to improved independence and quality of life for Veterans with stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exoskeleton

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04978467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing